Drug comparisons
Canagliflozin vs Tolazamide
Canagliflozin is SGLT2 inhibitor lowering blood sugar via kidney reabsorption with heart benefits. Tolazamide is sulfonylurea boosting insulin. Both differ in side effects.
No comparison dimensions are available for this page.
Clinical context
Individuals with type 2 diabetes seeking to compare SGLT2 inhibitors like Canagliflozin with sulfonylureas such as Tolazamide may consult this information when choosing oral antidiabetic therapy.
Bottom line
Both Canagliflozin and Tolazamide are viable oral antidiabetic options, with the optimal choice varying based on individual patient factors.
All medication comparisons